GE HealthCare Technologies Inc.

General ticker "GEHC" information:

  • Sector: Health Care
  • Industry: Medical - Healthcare Information Services
  • Capitalization: $34.2B (TTM average)

GE HealthCare Technologies Inc. follows the US Stock Market performance with the rate: 6.6%.

Estimated limits based on current volatility of 1.5%: low 63.89$, high 65.84$

Factors to consider:

  • Company included in S&P500 list
  • Company included in NASDAQ-100 index
  • Company pays dividends (irregularly): last record date 2026-04-03, amount 0.04$ (Y0.06%)
  • Total employees count: 54000 (+1.9%) as of 2025
  • China accounted for 10.9% of revenue in the fiscal year ended 2024-12-31
  • US accounted for 43.8% of revenue in the fiscal year ended 2024-12-31
  • Top business risk factors: Market competition, Geopolitical risks, Healthcare cost pressures, Strategic risks and growth management, R&D investment
  • Current price 11.3% below estimated low
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [71.31$, 100.46$]
  • 2026-12-31 to 2027-12-31 estimated range: [75.10$, 105.89$]

Financial Metrics affecting the GEHC estimates:

  • Negative: with PPE of 18.1 at the end of fiscal year the price was very high
  • Positive: 7.54 < Operating profit margin, % of 13.40
  • Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 5.51
  • Positive: -0.02 < Operating cash flow per share per price, % of 5.24
  • Positive: Interest expense per share per price, % of 1.16 <= 3.31
  • Negative: Investing cash flow per share per price, % of -2.76 <= -0.60
  • Positive: 19.24 < Shareholder equity ratio, % of 28.12 <= 42.59

Similar symbols

Short-term GEHC quotes

Long-term GEHC plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $19,552.00MM $19,672.00MM $20,625.00MM
Operating Expenses $17,117.00MM $17,047.00MM $17,862.00MM
Operating Income $2,435.00MM $2,625.00MM $2,763.00MM
Non-Operating Income $-74.00MM $-44.00MM $5.00MM
Interest Expense $542.00MM $504.00MM $440.00MM
R&D Expense $1,205.00MM $1,311.00MM $1,260.00MM
Income(Loss) $2,361.00MM $2,581.00MM $2,768.00MM
Taxes $743.00MM $531.00MM $614.00MM
Other Income(Loss) $-4.00MM $0.00MM $0.00MM
Net Income(Loss)* $1,568.00MM $1,993.00MM $2,084.00MM
Stockholders Equity $7,133.00MM $8,446.00MM $10,379.00MM
Inventory $1,960.00MM $1,939.00MM $2,234.00MM
Assets $32,454.00MM $33,089.00MM $36,906.00MM
Operating Cash Flow $2,101.00MM $1,951.00MM $1,987.00MM
Capital expenditure $387.00MM $401.00MM $482.00MM
Investing Cash Flow $-558.00MM $-914.00MM $-1,047.00MM
Financing Cash Flow $-478.00MM $-573.00MM $617.00MM
Earnings Per Share** $3.45 $4.37 $4.56

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.